Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Neogenomics Inc (NEO)

Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Humacyte’s $30 Million Stock Offering Fuels Growth Despite Insider Concerns Quiver Quantitative, Inc. - Tue Oct 15, 4:18AM CDT

Benchmark analyst Bruce Jackson maintained a Buy rating on Humacyte (HUMA) with a price target of $15.00, suggesting a significant upside for the company’s stock. Humacyte shares closed at $5.39 yesterday,...

HUMA : 5.39 (+6.73%)
EXAS : 69.80 (+1.26%)
NEO : 14.00 (+3.02%)
NeoGenomics: Q2 Earnings Snapshot AP - Mon Jul 29, 3:33PM CDT

NeoGenomics: Q2 Earnings Snapshot

NEO : 14.00 (+3.02%)
NeoGenomics: Q1 Earnings Snapshot AP - Tue Apr 30, 6:37AM CDT

NeoGenomics: Q1 Earnings Snapshot

NEO : 14.00 (+3.02%)
NeoGenomics: Q4 Earnings Snapshot AP - Tue Feb 20, 3:37PM CST

NeoGenomics: Q4 Earnings Snapshot

NEO : 14.00 (+3.02%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030 FinancialNewsMedia - Tue Jan 30, 8:15AM CST

EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NYSE:BMY),(NYSE:TMO),(NASDAQ:NTRA),(NASDAQ:NEO) EQNX::TICKER_END

TDSGF : 0.0811 (-22.84%)
TELO.VN : 0.130 (-7.14%)
BMY : 54.32 (-2.60%)
TMO : 557.92 (+2.12%)
NTRA : 124.16 (+2.65%)
NEO : 14.00 (+3.02%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030 GlobeNewswire - Tue Jan 30, 8:15AM CST

TDSGF : 0.0811 (-22.84%)
TELO.VN : 0.130 (-7.14%)
BMY : 54.32 (-2.60%)
TMO : 557.92 (+2.12%)
NTRA : 124.16 (+2.65%)
NEO : 14.00 (+3.02%)
Altice USA, PENN Entertainment rise; Hess, NeoGenomics fall, Thursday, 12/28/2023 Associated Press - Thu Dec 28, 2023

Stocks that traded heavily or had substantial price changes on Thursday: Altice USA, PENN Entertainment rise; Hess, NeoGenomics fall

ABX.TO : 26.60 (-1.15%)
BABA : 97.58 (-0.41%)
AMZN : 197.93 (+6.19%)
HES : 137.75 (+2.43%)
ATUS : 2.64 (+8.64%)
AAPL : 222.91 (-1.33%)
NEO : 14.00 (+3.02%)
NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response ACCESSWIRE - Tue Dec 5, 2023

FT. MYERS, FL / ACCESSWIRE / December 5, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, today announced new data highlighting its RaDaR® assay for minimal residual...

NEO : 14.00 (+3.02%)
NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference ACCESSWIRE - Tue Nov 14, 2023

FT. MYERS, FL / ACCESSWIRE / November 14, 2023 / NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, today announced the company will participate in the upcoming Piper Sandler...

NEO : 14.00 (+3.02%)
NeoGenomics: Q3 Earnings Snapshot AP - Mon Nov 6, 2023

NeoGenomics: Q3 Earnings Snapshot

NEO : 14.00 (+3.02%)

Barchart Exclusives

Thanks to Wall Street, Novo Nordisk Stock is Now a Buy Barchart - Sat Nov 2, 10:15AM CDT
Novo Nordisk has lost about a quarter of its value since the end of June. Meanwhile, indications are that its diabetes and weight-loss drugs may be useful in fighting cardiovascular disease, arthritis, opioid and alcohol addiction, and Alzheimer's. Novo remains a leader in the sector, and is trading at a valuation a third cheaper than competitor, Eli Lilly. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot